Ishita Drugs Announces 33rd AGM for FY25-26 on Sep 30, 2026

Ishita Drugs & Industries Ltd has filed its Annual Report for the Financial Year 2025-26, along with the Notice of its 33rd Annual General Meeting (AGM). The AGM is scheduled to be held on September 30, 2026. The report, submitted to the BSE, complies with SEBI (LODR) Regulations, 2015. Key agenda items include the re-appointment of Mrs. Abha Agrawal as a Non-Executive Non-Independent Director and the approval of related party transactions with Ishita Pharmaceuticals. The company's website will also host the annual report.